Screener

Every US-listed company's last full fiscal year, from its SEC filings. Find a business worth understanding first; its price comes after.

Revenue growthOver 20%FCF marginOver 20%Balance sheetNet cash

Add filter

Size

Over $200B $10B to $200B $2B to $10B Under $2B

Gross margin

Owner earnings

Stock pay

Share count

Coverage

18 companies

Company	Revenue	Growth	3 yr	Gross	Operating	FCF margin	Owner earnings	Stock pay	Net cash	Shares	Float
METAMeta Platforms, Inc.	$201.0B	+22.2%	+19.9%	82.0%	41.4%	22.9%	12.8%	10.2%	$1.5B	-1.5%	$1.60T
MUMicron Technology, Inc.	$133.2B	+256.3%	+104.6%	80.7%	74.6%	44.3%	43.3%	1.0%	$40.6B	+1.6%	$368.1B
LRCXLAM RESEARCH CORPORATION	$23.2B	+26.0%	+10.1%	50.5%	35.3%	21.1%	19.4%	1.7%	$3.7B	-2.3%	$178.3B
NEMNEWMONT CORPORATION	$22.7B	+21.3%	+23.9%	–	–	32.2%	31.8%	0.4%	$3.7B	-3.5%	$64.1B
TCOMTrip.com Group Limited	$8.9B	+22.2%	+45.4%	80.5%	25.2%	21.8%	18.1%	3.6%	$8.6B	+1.4%	–
TEAMAtlassian Corporation	$6.6B	+26.0%	+23.0%	84.8%	0.2%	20.1%	-4.4%	24.4%	$250.0M	-0.6%	$27.6B
FSLRFirst Solar, Inc.	$5.2B	+24.1%	+25.8%	40.6%	30.6%	22.7%	22.4%	0.4%	$1.6B	0.0%	$17.7B
RBLXRoblox Corporation	$4.9B	+35.8%	+30.0%	78.1%	-25.2%	27.7%	4.6%	23.1%	$2.2B	+6.5%	$65.5B
CRWDCROWDSTRIKE HOLDINGS, INC.Covered	$4.8B	+21.7%	+29.0%	74.7%	-6.1%	27.2%	4.4%	22.8%	$4.3B	+2.4%	$109.3B
UIUBIQUITI INC.	$3.3B	+27.2%	+19.0%	46.2%	36.2%	27.8%	27.5%	0.2%	$563.7M	+0.1%	$2.3B
PTCTPTC THERAPEUTICS, INC.	$1.7B	+114.5%	+35.3%	–	50.1%	40.6%	36.3%	4.3%	$1.6B	+14.9%	$3.4M
SLDESlide Insurance Holdings, Inc.	$1.2B	+36.5%	–	–	–	68.7%	67.7%	1.0%	$673.0M	+8.9%	$1.6B
NUTXNUTEX HEALTH INC.	$875.3M	+82.4%	+58.6%	50.8%	31.5%	28.1%	15.7%	12.3%	$174.1M	+23.0%	$524.0M
HRMYHARMONY BIOSCIENCES HOLDINGS, INC.	$868.5M	+21.5%	+25.6%	77.2%	24.0%	40.1%	34.9%	5.2%	$513.8M	+1.2%	$1.3B
DAVEDave Inc./DE	$554.2M	+59.7%	+39.3%	–	–	52.3%	46.9%	5.4%	$252.6M	+4.8%	$3.1B
AIIAmerican Integrity Insurance Group, Inc.	$276.5M	+35.3%	–	–	–	48.2%	44.3%	3.8%	$292.8M	+33.6%	$155.9M
TWFGTWFG, Inc.	$248.5M	+22.0%	+17.3%	–	14.9%	21.4%	19.5%	1.8%	$72.7M	+0.8%	$501.9M
AKBAAKEBIA THERAPEUTICS, INC.	$236.2M	+47.5%	-6.9%	83.3%	9.9%	28.7%	23.9%	4.8%	$106.0M	+21.9%	$946.4M

From SEC XBRL frames: each company's fiscal year closest to the calendar year, as filed. Float stands in for size: we show no market prices here. Cash-flow margins say little about banks and insurers. Figures refreshed 2026-11-01.